Ligand validation:7XRK

B12: COBALAMIN

B12 is a Ligand Of Interest in 7XRK designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7XRK_B12_B_301	79%	37%	0.118	0.964	1.28	1.19	8	13	2	0	100%	1
7XRK_B12_E_301	73%	38%	0.125	0.952	1.29	1.16	8	11	1	0	100%	1
5YRT_B12_K_1601	97%	30%	0.072	0.986	1.56	1.24	8	17	0	0	100%	1
5YRV_B12_K_1601	96%	29%	0.071	0.982	1.57	1.29	8	15	0	0	100%	1
7XRL_B12_B_301	95%	37%	0.079	0.981	1.26	1.21	8	13	1	0	100%	1
5YSH_B12_E_1601	85%	27%	0.105	0.971	1.58	1.35	8	19	3	0	100%	1
3KQ4_B12_A_2007	100%	12%	0.04	0.996	1.51	2.55	10	38	4	1	100%	1
8IXU_B12_A_501	100%	63%	0.045	0.99	0.63	0.79	1	3	0	0	100%	1
4LEM_B12_A_601	99%	19%	0.051	0.98	1.29	2.13	8	34	0	0	100%	1
5D08_B12_A_503	99%	55%	0.054	0.983	0.72	1.01	3	10	0	0	100%	1
8IXT_B12_A_501	99%	60%	0.064	0.991	0.7	0.81	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.